S Phase Cell Cycle Arrest and Apoptosis is Induced by Eugenol in G361 Human Melanoma Cells

  • Rachoi, Byul-Bo (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Shin, Sang-Hun (Department of Oral & Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Kim, Uk-Kyu (Department of Oral & Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Hong, Jin-Woo (Department of Korean Internal Medicine, School of Korean Medicine, Pusan National University) ;
  • Kim, Gyoo-Cheon (Department of Oral Anatomy, School of Dentistry, Pusan National University)
  • Received : 2011.05.23
  • Accepted : 2011.08.23
  • Published : 2011.09.30

Abstract

Eugenol is an essential oil found in cloves and cinnamon that is used widely in perfumes. However, the significant anesthetic and sedative effects of this compound have led to its use also in dental procedures. Recently, it was reported that eugenol induces apoptosis in several cancer cell types but the mechanism underlying this effect has remained unknown. In our current study, we examined whether the cytotoxic effects of eugenol upon human melanoma G361 cells are associated with cell cycle arrest and apoptosis using a range of methods including an XTT assay, Hoechst staining, immunocyto-chemistry, western blotting and flow cytometry. Eugenol treatment was found to decrease the viability of the G361 cells in both a time- and dose-dependent manner. The induction of apoptosis in eugenol-treated G361 cells was confirmed by the appearance of nuclear condensation, the release of both cytochrome c and AIF into the cytosol, the cleavage of PARP and DFF45, and the downregulation of procaspase-3 and -9. With regard to cell cycle arrest, a time-dependent decrease in cyclin A, cyclin D3, cyclin E, cdk2, cdk4, and cdc2 expression was observed in the cells after eugenol treatment. Flow cytometry using a FACScan further demonstrated that eugenol induces a cell cycle arrest at S phase. Our results thus suggest that the inhibition of G361 cell proliferation by eugenol is the result of an apoptotic response and an S phase arrest that is linked to the decreased expression of key cell cycle-related molecules.

Keywords

References

  1. Asha MK, Prashanth D, Murali B, Padmaja R, Amit A. Anthelmintic activity of essential oil of Ocimum sanctum and eugenol. Fitoterapia. 2001;72:669-70. https://doi.org/10.1016/S0367-326X(01)00270-2
  2. Atkins N, O'Brien E, Wesseling KH, Guelen II. Increasing observer objectivity with audio-visual technology: the Sphygmocorder. Blood Press Monit. 1999;72:269-272.
  3. Chogo JB, Crank G. Chemical composition and biological activity of the Tanzanian plant Ocimum suave. J Nat Prod. 1981;44:308-11. https://doi.org/10.1021/np50015a012
  4. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. Faseb J. 2000;14:729-39. https://doi.org/10.1096/fasebj.14.5.729
  5. Dreiling L, Hoffman S, Robinson WA. Melanoma: epidemiology, pathogenesis, and new modes of treatment. Adv Intern Med. 1996;41:553-604.
  6. Eberle J, Hossini AM. Expression and function of bcl-2 proteins in melanoma. Curr Genomics. 2008;9:409-19. https://doi.org/10.2174/138920208785699571
  7. Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches. Drug Resist Updat. 2007;10:218-34. https://doi.org/10.1016/j.drup.2007.09.001
  8. Evans T, Rosenthal ET, Youngblom J, Distel D, Hunt T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell. 1983;33:389-96. https://doi.org/10.1016/0092-8674(83)90420-8
  9. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem. 2005;280:5812-9. https://doi.org/10.1074/jbc.M411429200
  10. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalianfibroblasts. Cell. 1991;67:1169-79. https://doi.org/10.1016/0092-8674(91)90293-8
  11. Golab J, Stoklosa T, Czajka A, Dabrowska A, Jakobisiak M, Zagozdzon R, Wojcik C, Marczak M, Wilk S. Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice. Anticancer Res. 2000;20:1717-21.
  12. Henmi K, Hiwatashi Y, Hikita E, Toyama N, Hirano T. Methoxyand fluoro-chalcone derivatives arrest cell cycle progression and induce apoptosis in human melanoma cell A375. Biol Pharm Bull. 2009;32:1109-13. https://doi.org/10.1248/bpb.32.1109
  13. Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol. 2000; 36: 152-69. https://doi.org/10.1016/S1368-8375(99)00085-8
  14. Jiang CC, Yang F, Thorne RF, Zhu BK, Hersey P, Zhang XD. Human melanoma cells under endoplasmic reticulum stress acquire resistance to microtubule-targeting drugs through XBP- 1-mediated activation of Akt. Neoplasia. 2009;11:436-47. https://doi.org/10.1593/neo.09208
  15. Koo BC, Kim DH, Kim IR, Kim GC, Kwak HH, Park BS. A Natural Product, Chios Gum Mastic, Induces the Death of HL-60 Cells via Apoptosis and Cell Cycle Arrest. Int J Oral Biol. 2011;36:13-21.
  16. La Porta CA. Drug resistance in melanoma: new perspectives. Curr Med Chem. 2007;14:387-91. https://doi.org/10.2174/092986707779941078
  17. Lee SE, Hur YJ, Kim IR, Kwak HH, Kim GC, Shin SH, Kim CH, Park BS. Mechanism underlying Chios gum masticinduced apoptosis on SCC25 human tongue squamous cell carcinoma cell line. Int J Oral Biol. 2009;34:61-77.
  18. Markowitz K, Moynihan M, Liu M, Kim S. Biologic properties of eugenol and zinc oxide-eugenol. A clinically oriented review. Oral Surg Oral Med Oral Pathol. 1992;73:729-37. https://doi.org/10.1016/0030-4220(92)90020-Q
  19. Nakanishi M, Shimada M, Niida H. Genetic instability in cancer cells by impaired cell cycle checkpoints. Cancer Sci. 2006;97: 984-9. https://doi.org/10.1111/j.1349-7006.2006.00289.x
  20. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995;15:2612-24. https://doi.org/10.1128/MCB.15.5.2612
  21. Sakano K, Inagaki Y, Oikawa S, Hiraku Y, Kawanishi S. Coppermediated oxidative DNA damage induced by eugenol: possible involvement of O-demethylation. Mutat Res. 2004;565:35-44. https://doi.org/10.1016/j.mrgentox.2004.08.009
  22. Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79: 551-5. https://doi.org/10.1016/0092-8674(94)90540-1
  23. Singer JD, Gurian-West M, Clurman B, Roberts JM. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 1999;13:2375-87. https://doi.org/10.1101/gad.13.18.2375
  24. Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclindependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle. 2007; 6:2953-61. https://doi.org/10.4161/cc.6.23.4951
  25. Suzuki Y, Sugiyama K, Furuta H. Eugenol-mediated superoxide generation and cytotoxicity in guinea pig neutrophils. Jpn J Pharmacol. 1985;39:381-6. https://doi.org/10.1254/jjp.39.381
  26. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem. 2000;75:2288-97.
  27. Weber A, Kirejczyk Z, Potthoff S, Ploner C, Hacker G. Endogenous Noxa Determines the Strong Proapoptotic Synergism of the BH3-Mimetic ABT-737 with Chemotherapeutic Agents in Human Melanoma Cells. Transl Oncol. 2009;2:73-83. https://doi.org/10.1593/tlo.08223
  28. Wright SE, Baron DA, Heffner JE. Intravenous eugenol causes hemorrhagic lung edema in rats: proposed oxidant mechanisms. J Lab Clin Med. 1995;125:257-64.
  29. Xu X, Liu Y, Wang L, He J, Zhang H, Chen X, Li Y, Yang J, Tao J. Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells. Int J Dermatol. 2009;48:186-92. https://doi.org/10.1111/j.1365-4632.2009.03946.x